Additional commentary on deception in statin research

Expert Rev Clin Pharmacol. 2017 Dec;10(12):1411-1412. doi: 10.1586/17512433.2015.1102009. Epub 2015 Oct 23.

Abstract

Response to: Ferenci T. Absolute risk reduction may depend on the duration of the follow-up. Expert Rev Clin Pharmacol. 2017;10(12):1409-1410.

Publication types

  • Comment

MeSH terms

  • Deception
  • Follow-Up Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Numbers Needed To Treat
  • Research

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors